This is another testament to the comprehensive quality control capabilities of FIMAN, and lays a solid foundation for the compliance of future active collagen products entering the European market.

The White Paper offers a verifiable, quantifiable benchmark for the industry and shows that China has built a globally competitive innovation system for bioactive collagen biomaterials.

The future of Chinese collagen lies in the symbiosis of physicians, institutions and brands, and in every precious measure of trust between physicians and the people who seek beauty.

Deliver programs that fit better, work better and are more trustworthy, and keep serving every consumer well.

To be a long-term guardian of women's beauty through the professional prowess of collagen technology.

FIMAN has developed three application pathways across injectable,advancing comprehensive homeostatic remodeling of the dermal ECM microenvironment.

Building on China’s proprietary research and technological innovation, we continue to advance collagen science

FIMAN joined hands with renowned medical-aesthetic experts and Leyang Public Welfare to roll out a special science-education support initiative.